NAI’s core mission is to support our clients and advance responsible nutrition on a global scale. We achieve this through a dedication to excellence in everything we do – extending beyond our walls to ensure lasting partnerships with clients, employees, vendors, shareholders and the environment.
Mark LeDoux, CEO & Chairman, founded Natural Alternatives International in 1980, operating originally from his San Marcos, California home.
NAI opened its first official office and manufacturing facility in San Marcos, California. In addition to private label manufacturing for clients, NAI produced its own product lines.
NAI was incorporated.
NAI began trading publicly, on NASDAQ.
On September 9th, 1999, NAI had simultaneous grand opening celebrations of new manufacturing facilities in Vista, California and Lugano, Switzerland.
The California production facilities were increased to accommodate new growth and provide our clients with expanding capabilities.
NAI opened the Switzerland facility, Natural Alternatives International Europe, to accommodate our clients' global needs and growth.
In October of 1999, NAI issues the first patent for the CarnoSyn® beta-alanine instant release powder.
NAI commemorates its 25th year anniversary and celebrates an expansion of the Vista manufacturing facility to 100,000 square feet.
NAI produces the first batch of SR CarnoSyn® beta-alanine tablets for public sale.
NAI patents SR CarnoSyn® beta-alanine.
NAI celebrated 35 years in business and completed the expansion of the Vista, California location to 160,000 square feet, as well as expanding the Switzerland facility to 100,000 square feet.
NAI relocates its corporate headquarters to its new home in Carlsbad Research Center, Carlsbad, California.
NAI commercially launches in sports nutrition market.
SR CarnoSyn® sustained release beta-alanine receives Self-Affirmed GRAS Affirmation.
CarnoSyn® launches Beta-Alanine Loading & Dosing Education Initiative.
NAI debuts SR CarnoSyn® Wellness & Healthy Aging Market Expansion at SupplySide West.
NAI’s CarnoSyn® beta-alanine receives New Dietary Ingredient Status from the FDA.
NAI’s CarnoSyn® beta-alanine supplements are ruled “Patent Eligible” by the U.S. Court of Appeals.
NAI receives Self-Affirmed GRAS for their CarnoSyn® instant release beta-alanine.
NAI enters CarnoSyn® into the Japanese Market.
NAI’s CarnoSyn® wins NutraIngredients-USA 2019 Sports Nutrition Ingredient of the Year.
NAI’s CarnoSyn® is honored with the 2019 Novel Ingredient and Science Award by the Natural Products Association.
NAI is named Nutrition Industry Executive Supplier of the Month for December.
Stonegate Capital Partners initiates coverage on NAI.
NAI announces acquisition of manufacturing and warehouse facility in Carlsbad, CA to convert into a high-capacity powder blending/packaging facility.
NAI unveils new state-of-the-art booth at SupplySide West Expo.